Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0789
    -0.0005 (-0.04%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2624
    +0.0002 (+0.02%)
     
  • USD/JPY

    151.4670
    +0.0950 (+0.06%)
     
  • Bitcoin USD

    70,717.55
    +834.94 (+1.19%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,350.26
    +182.19 (+0.45%)
     

Danaher (DHR) Beats on Q4 Earnings & Revenues, Guides Well

Danaher Corporation DHR is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products.

DHR’s tried and tested business model – the Danaher Business System (‘DBS’) – has proved to be the fundamental growth driver, fueling revenue, margins, cash flow and earnings improvement. Moreover, DHR’s previously completed acquisitions have also been driving its top-line growth significantly. These strategic buyouts along with positive industry trends are expected to act as tailwinds.

However, DHR has faced stunted organic revenue growth in its dental segment, mainly attributable to weakness in higher-margin traditional consumables business. Moreover, softness in industrial markets in China, North America, Latin America and the Middle East has been severely impacting the company’s business.

DHR has consistently beaten earnings in the trailing four quarters, with an average positive surprise of 2.6%.

Currently, DHR has a Zacks Rank #3 (Buy) but that could change following its fourth-quarter 2017 earnings report which has just released. You can see the complete list of today’s Zacks #1(Strong Buy) Rank stocks here.

We have highlighted some of the key details from the just-released announcement below:

Earnings: Adjusted earnings per share for the fourth-quarter 2017 came in at $1.19, which beat the Zacks Consensus Estimate of $1.16.

Danaher Corporation Price and EPS Surprise

Danaher Corporation Price and EPS Surprise | Danaher Corporation Quote

Revenue: Revenues of $5,085.7 million topped the Zacks Consensus Estimate of $4,972 million.

Key Stats: Concurrent with the earnings release, provided its guidance for full-year 2018. The company projects adjusted earnings per share in the range of $4.25–$4.35. Overall, the company reported impressive key metrics largely driven by its effective business model, the DBS, which focuses on three critical areas -- quality, delivery, and cost & innovation.

Stock Price: DHR shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.

Check back later for our full write up on this DHR earnings report later!

Don’t Even Think About Buying Bitcoin Until You Read This

The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.

Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 4 crypto-related stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Danaher Corporation (DHR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement